Arbor Biotechnologies
John Murphy is the Chief Scientific Officer at Arbor Biotechnologies. He was formerly the Vice President of Biology and Rare Disease Research Unit at Pfizer.
John earned his PhD in Biochemistry from Columbia University in the City of New York.
Arbor Biotechnologies
2 followers
Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Arbor’s platform employs a diverse set of technologies and techniques – including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening – for accelerating the discovery of proteins for improving human health and sustainability.